Search - tctmd.com

Displaying 981 - 1000 of 1178

Sort: Relevancy | Date

News Industry News

EBR Systems Receives European CE Mark Approval for World’s First Wireless Cardiac Pacing System for Heart Failure

October 06, 2015

News Industry News

Extended Follow-Up Of ANTHEM-HF Patients Shows That Benefits Of Autonomic Regulation Therapy Are Maintained After 12 Months

September 28, 2015

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Daily News

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

Todd Neale

September 17, 2015

News Daily News

Short-term Readmission Rates Similar After TAVR vs SAVR

Todd Neale

September 10, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Conference News ESC 2015

NSAIDs Plus Anticoagulants a Bad Combination

Caitlin E. Cox

September 01, 2015

News Conference News ESC 2015

TECOS: No Differences in Heart Failure Outcomes When Sitagliptin Added to Usual Care in Diabetics

Yael L. Maxwell

August 31, 2015

News Conference News ESC 2015

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

L.A. McKeown

August 31, 2015

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

News Conference News ESC 2015

Failed Trial PRomPTs Questions About Role of Peri-Infarct Pacing for Remodeling of Large MIs

L.A. McKeown

August 30, 2015

News Daily News

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

Yael L. Maxwell

August 30, 2015

News Daily News

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

August 27, 2015

News Industry News

BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure

August 27, 2015

News Daily News

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

August 11, 2015

News Daily News

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

L.A. McKeown

August 03, 2015

News Industry News

Sorin Group Announces European Launch of REPLY CRT-P, the World’s Smallest Cardiac Resynchronization Pacemaker

July 31, 2015

News Daily News

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

July 30, 2015

Advertisement

EBR Systems Receives European CE Mark Approval for World’s First Wireless Cardiac Pacing System for Heart Failure

Extended Follow-Up Of ANTHEM-HF Patients Shows That Benefits Of Autonomic Regulation Therapy Are Maintained After 12 Months

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

Short-term Readmission Rates Similar After TAVR vs SAVR

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

NSAIDs Plus Anticoagulants a Bad Combination

TECOS: No Differences in Heart Failure Outcomes When Sitagliptin Added to Usual Care in Diabetics

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

Failed Trial PRomPTs Questions About Role of Peri-Infarct Pacing for Remodeling of Large MIs

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

Sorin Group Announces European Launch of REPLY CRT-P, the World’s Smallest Cardiac Resynchronization Pacemaker

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content